NCT00611689
- Conditions
- Neoplasms, Refractory Malignancy, Solid Tumors
- Locations
-
- Tennessee Oncology, PLLC Nashville, Tennessee, United States
Clinical trial condition
Refractory Malignancy
Explore clinical trials studying Refractory Malignancy. Study availability and eligibility vary by location and protocol.
4 public trials
0 recruiting studies
Refractory Malignancy trial results
NCT00613145
- Conditions
- Neoplasms, Refractory Malignancy
- Locations
-
- Tennessee Oncology, PLLC Nashville, Tennessee, United States
Completed
Phase I Study of Patupilone and RAD001
NCT00496600
- Conditions
- Neoplasms, Refractory Malignancy
- Locations
-
- The Cancer Institute of New Jersey New Brunswick, New Jersey, United States
NCT00611793
- Conditions
- Advanced Malignancies, Neoplasms, Refractory Malignancy
- Locations
-
- Tennessee Oncology, PLLC Nashville, Tennessee, United States